HK40022817B - Dual syringe with funnel feeding kit - Google Patents
Dual syringe with funnel feeding kit Download PDFInfo
- Publication number
- HK40022817B HK40022817B HK62020012676.6A HK62020012676A HK40022817B HK 40022817 B HK40022817 B HK 40022817B HK 62020012676 A HK62020012676 A HK 62020012676A HK 40022817 B HK40022817 B HK 40022817B
- Authority
- HK
- Hong Kong
- Prior art keywords
- kit
- vial
- solution
- spray
- syringe
- Prior art date
Links
Description
背景技术Background Technology
本公开涉及用于将流体从存储和重组容器转移到外科环境诸如手术室中的递送装置的方法、装置和套件。This disclosure relates to methods, apparatus, and kits for transferring fluids from storage and recombination containers to delivery devices in surgical environments such as operating rooms.
背景技术Background Technology
用于分配两种或更多种生物组分的滴注装置是已知的。在医疗装置领域,此类装置通常用于施加用于伤口闭合的生物粘合剂、聚合物和其它合成材料。由于用于形成生物粘合剂的生物组分的反应性质,因此在溶液准备好被施加之前,不对该组分进行混合。在施加之前太早混合组分可导致混合物过早聚合反应或硬化,由此造成无法施加溶液。因此,在已知的滴注装置中,两种或更多种组分保持分开,直到施加之前。滴注装置可包括用于在施加之前混合两种或更多种溶液的一个或多个预混装置。预混装置可为被动式的,即,管材中的螺旋构造,或相反可为主动式的,即,混合叶片或叶轮。一旦混合,则溶液可通过针状输出件施加或者相反可通过喷雾组件喷出。Infusion devices for dispensing two or more biological components are known. In the field of medical devices, such devices are commonly used to apply bioadhesives, polymers, and other synthetic materials for wound closure. Due to the reactive nature of the biological components used to form the bioadhesive, the components are not mixed until the solution is ready to be applied. Mixing the components too early before application can cause premature polymerization or hardening of the mixture, making it impossible to apply the solution. Therefore, in known infusion devices, the two or more components remain separate until application. Infusion devices may include one or more premixing devices for mixing two or more solutions before application. The premixing device may be passive, i.e., a helical structure in a tube, or conversely, active, i.e., mixing blades or impellers. Once mixed, the solution can be applied via a needle-like output or conversely, sprayed out via a spray assembly.
一种示例性装置教导于名称为“Biological Syringe System”的美国专利5,116,315中,该专利公开了一种用于递送混合组合物中的两种流体的系统,该系统包括歧管和排出组件。排出组件在混合空间中混合流体,并随后在喷雾器中使所混合的流体雾化成从组件递送。相似地,名称为“Apparatus for Spraying a mixture of Two Components”的美国专利5,605,255中所示的装置为一种用于喷射液体混合物的设备,该设备具有两个注射器、连接件、预混合室和位于预混合室下游的缩小容积部分、以及用于喷射该混合物的出口孔。该缩小容积部分终止于均化区。名称为“Turbulence Mixing Head for a TissueSealant Applicator and Spray Head for Same”的美国专利6,063,055示出了一种其中混合在混合头中进行的装置。An exemplary device is taught in U.S. Patent 5,116,315 entitled "Biological Syringe System," which discloses a system for delivering two fluids in a mixed composition, the system including a manifold and a discharge assembly. The discharge assembly mixes the fluids in a mixing space and then atomizes the mixed fluids in a sprayer for delivery from the assembly. Similarly, U.S. Patent 5,605,255 entitled "Apparatus for Spraying a mixture of Two Components" shows a device for spraying a liquid mixture having two syringes, a connector, a premixing chamber and a reduction volume section located downstream of the premixing chamber, and an outlet orifice for spraying the mixture. The reduction volume section terminates in a homogenization zone. U.S. Patent 6,063,055 entitled "Turbulence Mixing Head for a TissueSealant Applicator and Spray Head for Same" illustrates a device in which mixing takes place in a mixing head.
名称为“Apparatus for applying tissue sealant”的美国专利6,132,396公开了一种用于混合材料的第一组分和第二组分的歧管,该歧管包括具有第一入口端口和第二入口端口的主体、连接到该主体并具有出口的管状分配器以及与该出口流体连通的内部通道,该主体具有适于将第一组分从第一入口端口输送到内部通道的第一流体输送装置和适于将第二组分从第二入口端口输送到内部通道的第二流体输送装置,该第一流体输送装置包括与第一入口端口流体连接并具有设置在内部通道内的出口的皮下注射针,该第二流体输送装置包括位于主体中且与第二入口端口流体连接且具有设置在内部通道内的出口的通道,皮下注射针位于该通道中或能够穿透通道,由此第一组分和第二组分被第一输送装置和第二输送装置引导至管状分配器中进行混合,之后从管状分配器的出口中排出。U.S. Patent 6,132,396, entitled "Apparatus for applying tissue sealant," discloses a manifold for mixing a first component and a second component of a material. The manifold includes a body having a first inlet port and a second inlet port, a tubular dispenser connected to the body and having an outlet, and an internal channel in fluid communication with the outlet. The body has a first fluid delivery device adapted to deliver the first component from the first inlet port to the internal channel and a second fluid delivery device adapted to deliver the second component from the second inlet port to the internal channel. The first fluid delivery device includes a hypodermal needle fluidly connected to the first inlet port and having an outlet disposed within the internal channel. The second fluid delivery device includes a channel located within the body and fluidly connected to the second inlet port, having an outlet disposed within the internal channel. The hypodermal needle is located in or can penetrate the channel, thereby guiding the first and second components to the tubular dispenser for mixing, and then discharging from the outlet of the tubular dispenser.
名称为“Non-Clogging Airless Spray for High Viscosity,High SurfaceTension Fluids”的美国专利申请公布2013/0325059公开了一种用于喷射两种液体的医疗装置,该装置包括:第一注射器和第二注射器,每个注射器具有用于第一液体和第二液体的出口;连接件,该连接件具有与该注射器出口连通且终止于由喷雾器盖组成的远侧部件的第一通道和第二通道,喷雾器盖包括用于该第一液体和该第二液体的独立流体通道以及第一出口表面和第二出口表面;其中该喷雾器盖的第一出口表面和第二出口表面包括多个小出口孔,并且该第一出口孔和第二出口孔形成结合并混合离开装置的该第一液体和该第二液体的喷射图案。U.S. Patent Application Publication 2013/0325059, entitled "Non-Clogging Airless Spray for High Viscosity, High Surface Tension Fluids," discloses a medical device for spraying two liquids. The device includes: a first syringe and a second syringe, each syringe having an outlet for the first liquid and the second liquid; a connector having a first channel and a second channel communicating with the syringe outlets and terminating in a distal component consisting of a spray cap, the spray cap including separate fluid channels for the first liquid and the second liquid, and a first outlet surface and a second outlet surface; wherein the first outlet surface and the second outlet surface of the spray cap include a plurality of small outlet holes, and the first outlet holes and the second outlet holes form a spray pattern that combines and mixes the first liquid and the second liquid exiting the device.
美国专利8,506,547涉及一种利用包括主体的装置来将流体从非无菌区转移到外科环境内的无菌区的方法和装置,该主体具有与第一出口端口连通的第一入口端口。通常利用无菌注射器从患者中取出流体,并且将该流体转移到非无菌区,在该非无菌区处处理该流体。然后将经处理的流体吸入非无菌区中的另一个注射器内,并且将第一注射器的远侧端部放置在无菌主体的入口端口内。将第二无菌注射器的远侧端部插入到出口端口内,其中无菌注射器和非无菌注射器的远侧端部不接触。当柱塞被推压到第一非无菌注射器的腔室内以迫使流体流出第一注射器时,第二无菌注射器的柱塞被回缩,使得第二注射器中的腔室具有足够的容积以存储经处理的液体。由于第一非无菌注射器和第二无菌注射器在经处理的流体的转移期间不接触,因此无菌区被保持并且流体可用于外科手术中。U.S. Patent 8,506,547 relates to a method and apparatus for transferring fluid from a non-sterile area to a sterile area within a surgical environment using a device comprising a body having a first inlet port communicating with a first outlet port. Fluid is typically drawn from a patient using a sterile syringe and transferred to a non-sterile area where it is treated. The treated fluid is then aspirated into another syringe in the non-sterile area, and the distal end of the first syringe is placed within the inlet port of the sterile body. The distal end of a second sterile syringe is inserted into the outlet port, wherein the distal ends of the sterile and non-sterile syringes do not contact each other. When a plunger is pushed into the chamber of the first non-sterile syringe to force fluid out of the first syringe, the plunger of the second sterile syringe retracts such that the chamber in the second syringe has sufficient volume to store the treated fluid. Because the first non-sterile syringe and the second sterile syringe do not contact each other during the transfer of the treated fluid, the sterile area is maintained and the fluid is available for use in surgical procedures.
发明内容Summary of the Invention
本发明涉及多液体加载和递送套件,该套件包括用于第一活性组分的第一存储容器、用于第二活性组分的第二存储容器、至少两个转移注射器、至少两个小瓶适配器、具有贯通内腔的至少两个插管、以及多液体递送装置。递送装置具有:双中空料筒,每个料筒具有位于一个端部处的至少一个通孔和位于相对端部处的柱塞入口;撑脚架;可移除的双进料漏斗;具有可替换喷雾头的喷雾歧管;以及一个滴注头组件。在一个实施方案中,每个插管由柔性材料构成并且被提供有钝性无创伤端部头。This invention relates to a multi-liquid loading and delivery kit, comprising a first storage container for a first active component, a second storage container for a second active component, at least two transfer syringes, at least two vial adapters, at least two cannulas having a through-lumen, and a multi-liquid delivery device. The delivery device includes: dual hollow cartridges, each cartridge having at least one through-hole at one end and a plunger inlet at the opposite end; a support frame; a removable dual-feed funnel; a spray manifold with replaceable spray heads; and a drip head assembly. In one embodiment, each cannula is constructed of a flexible material and is provided with a blunt, non-invasive tip.
喷雾头组件可由多个元件构成,该多个元件包括具有双路开口的歧管、内部混合区域和雾化插件。另选地,滴注头组件可包括歧管,该歧管具有经由通道与柔性滴注出口流体连通的双路开口。喷雾头组件可直接附接到歧管或经由多内腔、柔性管连接到喷雾歧管。The spray head assembly may consist of multiple components, including a manifold with dual openings, an internal mixing zone, and an atomizing insert. Alternatively, the drip head assembly may include a manifold having dual openings in fluid communication with a flexible drip outlet via a channel. The spray head assembly may be directly attached to the manifold or connected to the spray manifold via a multi-lumen, flexible tube.
第一组分和第二组分呈固体形式、优选地为活性成分、更优选地为止血活性组分。出于本专利申请的目的,止血活性组分是指在暴露于血液或血浆衍生物时激活凝血形成剂或一旦被另一活性组分激活时形成凝块的组分。该组分中的至少一种可以冻干粉末的形式存储在小瓶中。在一个实施方案中,第一组分为凝血酶并且第二组分为源自血浆的止血活性提取物,更优选地,第二组分为纤维蛋白原。重组小瓶优选地包含能够溶解第一组分和第二组分的液体,诸如水溶液或包含钙盐的缓冲溶液。The first and second components are in solid form, preferably active ingredients, and more preferably hemostatic active components. For the purposes of this patent application, a hemostatic active component refers to a component that activates a coagulating agent upon exposure to blood or plasma derivatives or forms a clot once activated by another active component. At least one of these components may be stored in a vial in the form of a lyophilized powder. In one embodiment, the first component is thrombin and the second component is a hemostatic active extract derived from plasma, more preferably, the second component is fibrinogen. The reconstituted vial preferably contains a liquid capable of dissolving the first and second components, such as an aqueous solution or a buffer solution containing calcium salts.
本发明还涉及通过以下方式使用上述套件的方法:将重组组件放置在台上,将递送装置从包装转移到无菌区内,制备第一溶液,制备第二溶液,将双注射器系统的柱塞回缩到预定位置,将撑脚架旋转到打开位置,将第一插管和第二插管的端部通过用于每个料筒的圆筒的第一漏斗和第二漏斗插入双注射器系统中,利用歧管替换漏斗,以及将分配头附接到歧管。通过以下方式类似地制备第一溶液和第二溶液:将重组注射器上的小瓶适配器插入到包含溶解溶液的小瓶中,将溶解溶液吸入到注射器内,利用第一活性剂小瓶替换适配器上的溶解溶液小瓶,将溶解溶液注入到活性剂小瓶内,将包含活性剂的溶液抽吸到第一注射器内,以及利用第一插管替换小瓶适配器。The present invention also relates to a method of using the above-described kit in the following manner: placing the recombinant component on a table, transferring the delivery device from packaging to a sterile area, preparing a first solution, preparing a second solution, retracting the plunger of the dual-syringe system to a predetermined position, rotating the support bracket to an open position, inserting the ends of the first and second cannulas into the dual-syringe system through a first and second funnel for each cartridge, replacing the funnels with a manifold, and attaching the dispensing head to the manifold. The first and second solutions are prepared similarly by: inserting the vial adapter on the recombinant syringe into a vial containing a dissolving solution, drawing the dissolving solution into the syringe, replacing the dissolving solution vial on the adapter with a first surfactant vial, injecting the dissolving solution into the surfactant vial, drawing the solution containing the surfactant into the first syringe, and replacing the vial adapter with the first cannula.
附图说明Attached Figure Description
图1A为重组工具和无菌流体转移装置的示意性顶视图。Figure 1A is a schematic top view of the recombinant tool and the sterile fluid transfer device.
图1B为重组工具和无菌流体转移装置的透视图。Figure 1B is a perspective view of the recombinant tool and the sterile fluid transfer device.
图2A为如从顶部观察的处于转移模式的无菌递送装置的透视图,该无菌递送装置处于填充位置并且具有部署的撑脚架、附接的漏斗、以及回缩的柱塞。Figure 2A is a perspective view of a sterile delivery device in transfer mode as seen from top, in the filling position, with deployed support legs, an attached funnel, and a retractable plunger.
图2B为递送装置的示意性顶视图,该递送装置具有附接的漏斗、未回缩的柱塞、具有喷雾头的歧管、额外的喷雾头、以及具有滴注头的歧管。Figure 2B is a schematic top view of a delivery device having an attached funnel, an unretracted plunger, a manifold with a spray head, an additional spray head, and a manifold with a drip head.
图3为处于转移模式的无菌递送装置的透视图,该无菌递送装置具有部署的撑脚架、附接的漏斗、以及未回缩的柱塞。Figure 3 is a perspective view of a sterile delivery device in transfer mode, which has deployed support legs, an attached funnel, and an unretracted plunger.
图4为处于转移模式的无菌递送装置的透视图,该无菌递送装置具有回缩的撑脚架、附接的漏斗、以及未回缩的柱塞。Figure 4 is a perspective view of a sterile delivery device in transfer mode, which has retractable support legs, an attached funnel, and an unretractable plunger.
图5为处于滴注模式的无菌递送装置的透视图,该无菌递送装置具有部署的撑脚架、滴注头、以及未回缩的柱塞。Figure 5 is a perspective view of a sterile delivery device in drip mode, which has deployed support legs, a drip head, and an unretracted plunger.
图6为处于喷雾模式的无菌递送装置的顶视图,该无菌递送装置具有漏斗、混合和喷雾歧管、以及未回缩的柱塞。Figure 6 is a top view of the aseptic delivery device in spray mode, which has a funnel, a mixing and spray manifold, and an unretracted plunger.
图7A-图7O为示出本发明的套件和装置的操作过程步骤的图示。Figures 7A-7O are illustrations showing the operation steps of the kit and apparatus of the present invention.
具体实施方式Detailed Implementation
本发明涉及用于将流体从存储和重组容器转移到外科环境诸如手术室中的递送装置的方法、装置和套件。重组工具和存储容器大体示于图1A和图1B中,而递送装置10以转移模式示于图2-图4中并且以递送或滴注模式示于图5-图6中。图2B中的递送装置10具有被设置成双注射器构型的至少两个注射器,其中递送装置10和注射器可在具有递送装置10的套件中被单独地或一起地包装。This invention relates to methods, apparatus, and kits for transferring fluid from a storage and recombination container to a delivery device in a surgical environment such as an operating room. The recombination tool and storage container are generally shown in Figures 1A and 1B, while the delivery device 10 is shown in transfer mode in Figures 2-4 and in delivery or infusion mode in Figures 5-6. The delivery device 10 in Figure 2B has at least two syringes configured in a dual-syringe configuration, wherein the delivery device 10 and the syringes can be packaged individually or together in a kit containing the delivery device 10.
图1A中示出了一组重组工具,其包括一对加载注射器11、对应的存储小瓶13(1-4)、以及尖刺适配器15。在一个实施方案中,贮存小瓶13(1)和(2)包含基本上干燥的活性组分,优选冻干蛋白质或血浆源组分。在第一实施方案中,存储小瓶13(3)和(4)包含重组溶液,诸如盐水或缓冲水溶液。每个加载注射器11为中空圆柱形管,该中空圆柱形管具有柄部17、位于柄部17的远侧的端部处的出口23、以及柱塞臂19,该柱塞臂穿过柄部17中的开口21紧密地适配在加载注射器11的内部空间内。回缩柱塞臂19在柱塞臂19的基部与加载注射器11的出口23之间产生空的空间。尖刺适配器15被配置成接纳小瓶13并且同时利用尖刺9刺穿小瓶隔膜。无菌、非金属插管8被提供用于将吸入注射器11内的重组材料后续地转移到递送装置10内。Figure 1A shows a set of recombination tools including a pair of loading syringes 11, corresponding storage vials 13 (1-4), and a spike adapter 15. In one embodiment, storage vials 13 (1) and (2) contain substantially dried active components, preferably lyophilized proteins or plasma-derived components. In a first embodiment, storage vials 13 (3) and (4) contain recombination solutions, such as saline or buffered aqueous solutions. Each loading syringe 11 is a hollow cylindrical tube having a handle 17, an outlet 23 at a distal end of the handle 17, and a plunger arm 19 that fits snugly within the internal space of the loading syringe 11 through an opening 21 in the handle 17. Retracting the plunger arm 19 creates an empty space between the base of the plunger arm 19 and the outlet 23 of the loading syringe 11. The spike adapter 15 is configured to receive the vial 13 and simultaneously pierce the vial septum with a spike 9. A sterile, non-metallic cannula 8 is provided for subsequently transferring the recombinant material in the aspiration syringe 11 into the delivery device 10.
装置10以加载构型示于图2-图4中并且以滴注构型示于图5和图6中。在任一构型中,装置10包括以市售注射器12形式提供的两个供给容器,该供给容器用于生物制剂(诸如蛋白质、诸如纤维蛋白原)的溶液、以及纤维蛋白原激活剂(诸如凝血酶)的溶液、双组分组织胶的溶液。每个注射器12包括中空圆柱形注射器主体14,该注射器主体具有前端16和开放后端22(未示出),该前端具有端口18和连接件90。每个注射器主体14中布置有密封邻接在注射器主体14的内表面上的活塞或柱塞24。活塞24由活塞杆26保持,该活塞杆通过后端22从注射器主体14导出。活塞杆26分别沿注射器主体14的纵向延伸并延伸超过开放后端22。活塞杆26的背向活塞24的自由端30具有形成于其上的环形凸缘32。这些环形凸缘32通过连接元件34彼此机械地连接。连接元件34形成有两个接收凹槽36,该凹槽为侧向开放的且适于将环形凸缘32插入其中。该两个注射器主体14通过夹具保持部件38(在下文中被称作保持元件)彼此连接。每个注射器12的底部部分16包括基本上平坦的底部表面,该底部表面包括通向左侧腔体和右侧腔体的开口。左侧腔体和右侧腔体彼此分开并且包括形成截头锥形腔体的渐缩侧壁。左侧入口端口利用左侧通孔与左侧出口端口流体连通。右侧入口端口利用右侧通孔与右侧出口端口流体连通。The device 10 is shown in a loading configuration in Figures 2-4 and in a drip configuration in Figures 5 and 6. In either configuration, the device 10 includes two supply containers provided in the form of commercially available syringes 12 for solutions of biological agents (such as proteins, such as fibrinogen), and solutions of fibrinogen activators (such as thrombin), and solutions of two-component tissue glue. Each syringe 12 includes a hollow cylindrical syringe body 14 having a front end 16 and an open rear end 22 (not shown), the front end having a port 18 and a connector 90. A piston or plunger 24 is arranged in each syringe body 14 and sealed abuts against the inner surface of the syringe body 14. The piston 24 is held by a piston rod 26 that extends from the syringe body 14 through the rear end 22. The piston rod 26 extends longitudinally along the syringe body 14 and extends beyond the open rear end 22. The free end 30 of the piston rod 26 facing away from the piston 24 has an annular flange 32 formed thereon. These annular flanges 32 are mechanically connected to each other by connecting elements 34. Connecting elements 34 form two receiving grooves 36, which are laterally open and adapted for insertion of the annular flanges 32. The two syringe bodies 14 are connected to each other by clamping retaining members 38 (hereinafter referred to as retaining elements). The bottom portion 16 of each syringe 12 includes a substantially flat bottom surface with openings leading to a left and right cavity. The left and right cavities are separated from each other and include tapered sidewalls forming truncated conical cavities. The left inlet port is in fluid communication with the left outlet port via a left through-hole. The right inlet port is in fluid communication with the right outlet port via a right through-hole.
在一种另选的加载构型中,具体地如图3和图4所示,装置10包括部署的撑脚架80和附接的漏斗100。漏斗100为具有两个锥形开口110、120的双漏斗,该两个锥形开口通过连接部分115接合并且被配置用于同时附接到两个注射器14。锥形开口110、120与端口18对准。螺母90被配置成将漏斗100可释放地附接到端口。在一个实施方案中,漏斗100通过压力配合附接到与每个注射器14上的渐缩内表面对应的外表面,而非通过经由螺钉和/或鲁尔螺母的锁定。为了将初始液体转移到每个注射器14内,利用钝性软插管8替换每个重组注射器11的小瓶尖刺适配器15。插管8用于通过对应于每个注射器14的开口110、120将液体递送到递送装置注射器内。双锥形漏斗100为插管放置提供较大的目标。每个锥形开口110、120将插管8和液体引导到注射器14的每个圆筒内。钝头软插管8,尤其是在与漏斗100联合使用时,提供了将液体递送到装置10内的较安全、较容易和较快速的装置。In an alternative loading configuration, specifically as shown in Figures 3 and 4, the device 10 includes a deployed support frame 80 and an attached funnel 100. The funnel 100 is a double funnel with two tapered openings 110, 120, which engage via a connecting portion 115 and are configured for simultaneous attachment to two syringes 14. The tapered openings 110, 120 are aligned with a port 18. A nut 90 is configured to releasably attach the funnel 100 to the port. In one embodiment, the funnel 100 is attached by pressure fitting to an outer surface corresponding to a tapered inner surface on each syringe 14, rather than by locking via screws and/or Luer nuts. To transfer initial fluid into each syringe 14, a blunt flexible cannula 8 replaces the vial spike adapter 15 of each recombinant syringe 11. The cannula 8 is used to deliver fluid into the delivery device syringe through the openings 110, 120 corresponding to each syringe 14. The double-tapered funnel 100 provides a larger target for cannula placement. Each conical opening 110, 120 guides the cannula 8 and the liquid into each cylinder of the syringe 14. The blunt-tipped soft cannula 8, especially when used in conjunction with the funnel 100, provides a safer, easier, and faster means of delivering liquid into the device 10.
应当理解,可根据本发明的实施方案使用任何类型的头,包括混合头、混合喷雾头、混合滴注头、空气辅助式、无空气式喷雾头等。虽然一些附图示出了滴注头并且其他附图示出了喷雾头,但用于混合和挤出两种组分的任何头均可用于本系统中。It should be understood that any type of head, including mixing heads, mixing spray heads, mixing drip heads, air-assisted spray heads, airless spray heads, etc., can be used according to embodiments of the invention. Although some figures show drip heads and others show spray heads, any head used for mixing and extruding two components can be used in this system.
在一个另选的滴注构型中,如图5和图6所示,装置10包括歧管60,该歧管包括基本上为Y形的构件,该基本上为Y形的构件具有第一近侧延伸部62和第二近侧延伸部64以及远侧延伸部66。近侧延伸部62、64被配置用于与第一组分源和第二组分源(例如,注射器14)可操作地接合。远侧延伸部66被配置用于与细长轴68可操作地接合,如下文将更详细论述。歧管60还包括第一组分通道和第二组分通道(未示出)。第一组分通道和第二组分通道使第一组分源和第二组分源与形成于细长轴68中的第一内腔73和第二内腔75(未示出)流体连通。虽然歧管60(如图所示)被配置成仅接收两个组分源,但可设想出歧管60可被配置成接收多于两个生物组分源和/或医用组分源。螺母90被配置成将歧管60附接和固定到入口端口18。In an alternative infusion configuration, as shown in Figures 5 and 6, device 10 includes a manifold 60 comprising a substantially Y-shaped member having a first proximal extension 62, a second proximal extension 64, and a distal extension 66. The proximal extensions 62 and 64 are configured for operatively engaging with a first component source and a second component source (e.g., syringe 14). The distal extension 66 is configured for operatively engaging with an elongated shaft 68, as will be discussed in more detail below. Manifold 60 also includes a first component channel and a second component channel (not shown). The first and second component channels provide fluid communication between the first and second component sources and a first lumen 73 and a second lumen 75 (not shown) formed in the elongated shaft 68. While manifold 60 (as shown) is configured to receive only two component sources, it is contemplated that manifold 60 could be configured to receive more than two biological component sources and/or medical component sources. Nut 90 is configured to attach and secure manifold 60 to inlet port 18.
细长轴68可限定由有机硅、塑料、聚合物或其他柔性材料构成的基本上为固体的主体。如上所述,细长轴68包括延伸其长度的第一组分内腔73和第二组分内腔75。由可锻塑材料构成的线材(未示出)也可延伸细长轴68的长度。线材76可在细长轴68已弯曲或挠曲以适应给定手术操作之后使细长轴68保持弯曲或挠曲构型。细长轴68固定到歧管60的远侧延伸部66,使得第一组分内腔73和第二组分内腔75与第一组分通道和第二组分通道对准。另选地,细长轴68可在歧管60的远侧端部处一体地形成。如图2A、图5、图6所示,装置10可与连接到细长轴68(其与喷雾头或滴注头70端接)的歧管60一起使用,或者另选地,头70可直接附接到歧管60而不具有细长轴68。The elongated shaft 68 may define a substantially solid body made of silicone, plastic, polymer, or other flexible material. As described above, the elongated shaft 68 includes a first component lumen 73 and a second component lumen 75 extending its length. A filament (not shown) made of a malleable material may also extend the length of the elongated shaft 68. A filament 76 may maintain the elongated shaft 68 in a bent or flexed configuration after it has been bent or flexed to accommodate a given surgical procedure. The elongated shaft 68 is secured to the distal extension 66 of the manifold 60 such that the first component lumen 73 and the second component lumen 75 are aligned with the first component channel and the second component channel. Alternatively, the elongated shaft 68 may be integrally formed at the distal end of the manifold 60. As shown in Figures 2A, 5, and 6, the device 10 may be used with a manifold 60 connected to the elongated shaft 68 (which terminates with a spray head or drip head 70), or alternatively, the head 70 may be directly attached to the manifold 60 without having the elongated shaft 68.
图7示出了将液体组分转移到递送装置10内并且随后从加载构型转换到分配或喷雾构型所需的主要步骤。首先,使具有小瓶适配器15的第一注射器11刺穿包含重组溶液的存储小瓶13(3)中的顶部阻隔层,并且以常规方式抽吸其中的液体。在第一注射器11的端部上将存储小瓶13(3)替换成存储小瓶(1),该存储小瓶(1)优选地包含例如基本上呈固体形式的纤维蛋白原。将重组溶液分配到存储小瓶(1)内以溶解其中的材料。然后将重组液体吸回到第一注射器11内,并且利用第一插管8替换小瓶适配器15。在第二注射器11中利用存储小瓶(2)和(4)以及第二插管8重复这些步骤。在任一种或两种情况下,可通过搅拌和温和加热来加速重组过程。Figure 7 illustrates the main steps required to transfer the liquid component into the delivery device 10 and subsequently switch from a loading configuration to a dispensing or spraying configuration. First, a first syringe 11 with a vial adapter 15 is used to puncture the top barrier layer of a storage vial 13(3) containing the recombinant solution, and the liquid is aspirated in a conventional manner. At the end of the first syringe 11, the storage vial 13(3) is replaced with a storage vial (1), which preferably contains, for example, fibrinogen in substantially solid form. The recombinant solution is dispensed into the storage vial (1) to dissolve the material therein. The recombinant liquid is then aspirated back into the first syringe 11, and the vial adapter 15 is replaced using a first cannula 8. These steps are repeated in a second syringe 11 using storage vials (2) and (4) and a second cannula 8. In either or both cases, the recombinant process can be accelerated by stirring and gentle heating.
为了加载的目的,通过旋转约90度并且通过将注射器柱塞30牵拉(或回缩)到预定位置来将撑脚架80部署在装置10上。架80相对于柱塞柄部30抬高注射器14的入口,从而允许重组液体完全流入到每个注射器14内。为了防止架80旋摆而关闭,可提供棘爪以将其锁定在打开位置或闭合位置。一旦重组液体已被转移到装置10的每个注射器14内,就优选地利用装置10上的棘爪或其他固定装置来将撑脚架80旋转到锁定喷雾位置。漏斗100被移除并且被替换成歧管60和相关联的喷雾头元件。装置10现在可用于以常规方式喷射多液体组分,尤其是双组分制剂,诸如纤维蛋白原和凝血酶。For loading purposes, the support frame 80 is deployed on the device 10 by rotating approximately 90 degrees and by pulling (or retracting) the syringe plunger 30 to a predetermined position. The support frame 80 elevates the inlet of the syringe 14 relative to the plunger handle 30, thereby allowing the reconstituted fluid to flow completely into each syringe 14. To prevent the support frame 80 from swinging and closing, a pawl is provided to lock it in an open or closed position. Once the reconstituted fluid has been transferred into each syringe 14 of the device 10, the support frame 80 is preferably rotated to a locked spray position using the pawl or other securing device on the device 10. The funnel 100 is removed and replaced with a manifold 60 and associated spray head elements. The device 10 can now be used to spray multi-liquid components, especially two-component formulations such as fibrinogen and thrombin, in a conventional manner.
Claims (14)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/623791 | 2017-06-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK40022817A HK40022817A (en) | 2020-11-20 |
| HK40022817B true HK40022817B (en) | 2024-08-09 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110753518B (en) | Dual syringe with funnel feed kit | |
| CN107635611B (en) | Methods and devices for co-delivery of liquid and powdered hemostats and sealants | |
| US7018357B2 (en) | External mixer assembly | |
| EP1047464B1 (en) | Two component dispenser system | |
| AU2002238143A1 (en) | External mixer assembly | |
| KR20150056570A (en) | Airless, non-clogging tip assembly and device | |
| US20250143681A1 (en) | Systems, devices and methods for reconstituting therapeutic powders, mixing precursor solutions, and expressing sealants for controlling bleeding and sealing fluid and air leaks | |
| US12114843B2 (en) | Sealant applicators having mixing and spraying assemblies with malleable sections and spray tips having reduced dimensions | |
| JP7694927B2 (en) | Combined hemostatic powder and liquid delivery device for controlling bleeding and sealing tissue at a surgical site - Patent Application 20070233633 | |
| HK40022817B (en) | Dual syringe with funnel feeding kit | |
| HK40022817A (en) | Dual syringe with funnel feeding kit | |
| RU225390U1 (en) | ADAPTER FOR CONNECTING A STERILE SOLUTION SPRAYER WITH A BOTTLE WITH STERILE SOLUTION | |
| JP2022146896A (en) | Sprayer and anti-clogging container for biological tissue adhesive | |
| EP1917914B1 (en) | External mixer assembly |